Crispr Therapeutics Ag (CRSP)

R&D Expense Growth

-5.28%

Quarterly · Period ending:

CRSP logo

CRSP R&D Expense Growth

Latest reported-5.28%
CRSP Quarterly R&D Growth (QoQ) (0.00% → -5.28%)
High-resolution chart · PNG

CRSP r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-5.2819%
-11.9322%
32.1942%
-9.7896%
-9.9194%
-11.7717%
6.1983%
2.7084%
5.5804%
-25.02%
4.902%
-10.6908%
1.6211%
-3.4957%
-11.2046%
-5.357%
4.2099%
14.6952%
23.4671%
1.4186%
16.5845%
-14.2597%
15.994%
19.5824%
9.5713%
11.1401%
-14.822%
44.8056%
16.8855%
17.4334%
-27.672%
55.3466%
31.3233%
-2.5512%
12.2443%
4.2348%
15.6366%
-4.9255%
29.2068%
40.107%
43.0805%
-2.6239%
64.6839%
152.288%
27.6632%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.